StockWatch
·

Senores Pharmaceuticals Ltd Q2 FY26 Results

SENORESQ2 FY26 Results
Filing
MetricValue ( Cr)vs Q1 FY26
Revenue161.7617.2%
Total Income167.1718.3%
Expenditure126.5310.2%
PBT40.6453.4%
Net Profit30.1242.2%
OPM30.61%5.85pp
NPM18.02%3.04pp
EPS6.5442.2%
View full financials

Informational and educational content only. Not investment advice.